
The acquisition brings Gallant’s experimental stem cell treatments for feline chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Feline cancer presented by age
Feline cancer presented by age
Feline cancer presented by age





